Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis

被引：92

作者：

Cipriani, S. ^{[1
]}

Chen, Xiqun ^{[1
]}

Schwarzschild, Michael A. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02129 USA

来源：

BIOMARKERS IN MEDICINE | 2010年 / 4卷 / 05期

关键词：

blood; cerebrospinal fluid; oxidative stress; Parkinson's disease; prognosis; substantia nigra; urate; SERUM URIC-ACID; BLOOD-BRAIN-BARRIER; PLASMA URATE; OXIDANT STRESS; PEROXYNITRITE; CONSUMPTION; PROGRESSION; METABOLISM; RADICALS; ALCOHOL;

D O I：

10.2217/BMM.10.94

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

A growing number of studies have correlated higher urate levels with a lower risk of developing Parkinson's disease (PD) and with a favorable rate of disease progression, indicating that urate could be an important biomarker of the pathophysiology underlying PD. Dietary and genetic determinants of urate have also been linked to a reduced risk or delayed onset of PD. Based on the known antioxidant and metal complexing properties of urate, together with evidence for oxidative stress as a contributor to neurodegeneration in PD, urate may serve as an endogenous neuroprotectant that helps reduce the risk and rate of the disease. In this article we review the convergent biological, epidemiological and clinical data that identify urate as a promising biomarker of the risk, diagnosis and prognosis of PD.

引用

收藏

页码：701 / 712

页数：12

相关论文

共 82 条

[1] NO EVIDENCE FOR SYSTEMIC OXIDANT STRESS IN PARKINSONS OR ALZHEIMERS-DISEASE [J].

AHLSKOG, JE ;

UITTI, RJ ;

LOW, PA ;

TYCE, GM ;

NICKANDER, KK ;

PETERSEN, RC ;

KOKMEN, E .

MOVEMENT DISORDERS, 1995, 10 (05) :566-573

[2] URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].

AMES, BN ;

CATHCART, R ;

SCHWIERS, E ;

HOCHSTEIN, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862

[3] Dopamine and uric acid act as antioxidants in the repair of DNA radicals: Implications in Parkinson's disease [J].

Anderson, RF ;

Harris, TA .

FREE RADICAL RESEARCH, 2003, 37 (10) :1131-1136

[4] Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration [J].

Andreadou, Elisabeth ;

Nikolaou, Chryssoula ;

Gournaras, Filippos ;

Rentzos, Michael ;

Boufidou, Fotini ;

Tsoutsou, Anthoussa ;

Zournas, Christos ;

Zissimopoulos, Vassilis ;

Vassilopoulos, Demetrios .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (09) :724-728

[5] Uric acid associates with cognition in Parkinson's disease [J].

Annanmaki, Tua ;

Pessala-Driver, Anniina ;

Hokkanen, Laura ;

Murros, Kari .

PARKINSONISM & RELATED DISORDERS, 2008, 14 (07) :576-578

[6] Low plasma uric acid level in Parkinson's disease [J].

Annanmaki, Tua ;

Muuronen, Antti ;

Murros, Kari .

MOVEMENT DISORDERS, 2007, 22 (08) :1133-1137

[7]

[Anonymous], SAF UR EL PARK DIS S

[8] INACTIVATION OF ALPHA-ANTIPROTEINASE BY HYDROXYL RADICALS - THE EFFECT OF URIC-ACID [J].

ARUOMA, OI ;

HALLIWELL, B .

FEBS LETTERS, 1989, 244 (01) :76-80

[9] Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease [J].

Ascherio, Alberto ;

LeWitt, Peter A. ;

Xu, Kui ;

Eberly, Shirley ;

Watts, Arthur ;

Matson, Wayne R. ;

Marras, Connie ;

Kieburtz, Karl ;

Rudolph, Alice ;

Bogdanov, Mikhail B. ;

Schwid, Steven R. ;

Tennis, Marsha ;

Tanner, Caroline M. ;

Beal, M. Flint ;

Lang, Anthony E. ;

Oakes, David ;

Fahn, Stanley ;

Shoulson, Ira ;

Schwarzschild, Michael A. .

ARCHIVES OF NEUROLOGY, 2009, 66 (12) :1460-1468

[10] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

← 1 2 3 4 5 6 7 8 9 →